Adjust Font Sizing:

December 10, 2024 Clinical Update Webinar: Narcolepsy Type 1 and Orexin

November 20th, 2024


Join us via Zoom on Tuesday, December 10th at 6pm ET / 3pm PT for the last Clinical Update Webinar in our 2024 series. Dr. Oliver Sum-Ping will discuss orexin, which is a neuropeptide that plays an important role in several biological functions, especially the regulation of sleep and wakefulness. People with Narcolepsy Type 1 (NT1) have low levels of orexin. This presentation will review orexin’s function, its role in NT1, and explore the potential for new treatments focusing on orexin receptor agonists that may treat NT1.

We will answer your questions live! Or feel free to share them in advance via email by Tuesday, December 3rd.

Presented by:

Dr. Oliver Sum-Ping is a sleep neurologist and a Clinical Associate Professor in the Division of Sleep Medicine within Stanford’s Department of Psychiatry and Behavioral Sciences. While he treats patients with all sleep disorders, he has particular clinical interest in disorders of hypersomnolence, serving as the Director of Stanford’s Hypersomnolence Clinic. In addition to his clinical practice, he has interest in research with a focus on novel technologic applications for diagnosis of sleep disorders. He also is highly involved in sleep education and serves as the Associate Program Director for Stanford’s Sleep Fellowship.

Thank you to Takeda for sponsoring this webinar:

# # #
Date Created: November 20th, 2024
Last Updated: November 25th, 2024